Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001661460-15-000001
Filing Date
2015-12-24
Accepted
2015-12-23 21:45:42
Documents
1
Effectiveness Date
2015-12-24
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6434
  Complete submission text file 0001661460-15-000001.txt   7478
Mailing Address 4250 EXECUTIVE SQUARE, SUITE 900 LA JOLLA CA 92037
Business Address 4250 EXECUTIVE SQUARE, SUITE 900 LA JOLLA CA 92037 858-242-1576
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-253835 | Film No.: 151306877